miR‑150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma.
about
Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinomaPhospholipid Phosphatase 4 promotes proliferation and tumorigenesis, and activates Ca2+-permeable Cationic Channel in lung carcinoma cells.Epigenetic mediated zinc finger protein 671 downregulation promotes cell proliferation and tumorigenicity in nasopharyngeal carcinoma by inhibiting cell cycle arrest.Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.Downregulation of miR-874-3p promotes chemotherapeutic resistance in colorectal cancer via inactivation of the Hippo signaling pathway.miR‑149‑5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway.Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-apoptotic proteins.Comprehensive analysis of differential expression profiles reveals potential biomarkers associated with the cell cycle and regulated by p53 in human small cell lung cancer.miR-1266 Contributes to Pancreatic Cancer Progression and Chemoresistance by the STAT3 and NF-κB Signaling Pathways.Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling.
P2860
Q40977712-3734CABB-3DCA-4815-88CE-28B7361204DAQ41163315-72F49265-1C22-4ADC-B9D9-4A3E4716D946Q41558346-EC577250-2502-47B6-95C5-B29ECBB0F716Q42668878-B6CB60C6-D51E-4BF6-952E-0468CA4921FBQ47146670-0211753B-FE1F-424B-A7AB-8EC5C30B24D5Q48629122-99BAD394-20EF-453B-B071-30D7955964BBQ49379529-805D3B85-0648-4DCE-A559-6B5C09269468Q49461890-3A7488E5-586D-43BA-ADA2-689EE5A4C914Q49802266-4925FA90-F5E6-4CD3-9440-646B7632EACDQ52641306-247DFAD4-5EDC-4489-8F4E-F85ADB6C016FQ52653074-415E04D2-8C19-4E23-9E32-79A4856E8227Q55368106-F161AF32-8F40-4E42-A19E-169A7D9E0704Q55636279-6632550B-9B3A-4D6A-AEDB-9CA2FD595B08
P2860
miR‑150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
miR‑150 inhibits proliferation ...... n in nasopharyngeal carcinoma.
@en
miR‑150 inhibits proliferation ...... n in nasopharyngeal carcinoma.
@nl
type
label
miR‑150 inhibits proliferation ...... n in nasopharyngeal carcinoma.
@en
miR‑150 inhibits proliferation ...... n in nasopharyngeal carcinoma.
@nl
prefLabel
miR‑150 inhibits proliferation ...... n in nasopharyngeal carcinoma.
@en
miR‑150 inhibits proliferation ...... n in nasopharyngeal carcinoma.
@nl
P2093
P2860
P356
P1476
miR‑150 inhibits proliferation ...... n in nasopharyngeal carcinoma.
@en
P2093
Caihong Li
Haiqing Luo
Keyuan Zhou
Meilian Liu
Ronggang Li
Xiangyong Li
P2860
P356
10.3892/IJO.2017.3909
P50
P577
2017-03-10T00:00:00Z